text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "T cells"
Too many choices? Use the filter option on the left to narrow your product listing.
261-270 of 1015 results
  • P5 Primary Cell 96-well Nucleofector® Kit
    Compare
    P5 Primary Cell 96-well Nucleofector® Kit
    Catalog #: V4SP-5096

    For medium-throughput transfection of primary cells, e.g. HUVEC, when working with the 4D-Nucleofector® 96-well Unit.

    Sales unit: kit
    SA
  • HepaRG™ Differentiation Medium Supplement
    Compare
    HepaRG™ Differentiation Medium Supplement
    Catalog #: ADD721C
    HepaRGTM Differentiation Medium Supplement is used to support the differentiation of the proliferating HepaRGTM101 cells into the mature hepatic-like phenotype.
    Sales unit: Bottle
    BOT
  • Rat Brain Cortex Astrocytes
    Compare
    Rat Brain Cortex Astrocytes
    Catalog #: R-CXAS-520
    Cryopreserved ampule of Rat Brain Cortex Astrocytes containing ≥ 1 million cells
    Sales unit: each
    EA
  • Rat Brain Hippocampus Astrocytes
    Compare
    Rat Brain Hippocampus Astrocytes
    Catalog #: R-HIAS-521

    Cryopreserved ampule of Rat Brain Hippocampus Astrocytes containing ≥1 million cells

    Sales unit: each
    EA
  • SCBM™ Stromal Cell Growth Basal Medium
    Compare
    SCBM™ Stromal Cell Growth Basal Medium
    Catalog #: CC-3204
    SCBMTM Stromal Cell Basal Medium
    Sales unit: each
    EA
  • Pro293s™ Serum-free Medium – Chemically Defined for 293 Cells in Suspension
    Compare
    Pro293s™ Serum-free Medium – Chemically Defined for 293 Cells in Suspension
    Catalog #: BEBP02-025Q
    Pro293s™ Serum-free medium CD for suspension cells, without L-glutamine, phenol red, galactose or Pluronic® F-68, 1 L
    Sales unit: each
    EA
  • Pro293™ a Serum-free Medium – Chemically Defined for 293 Adherent Cells
    Compare
    Pro293™ a Serum-free Medium – Chemically Defined for 293 Adherent Cells
    Catalog #: BEBP12-764Q
    Pro293™ serum-free medium Chemically Defined for adherent cells, without L-glutamine or phenol red with 0.1% Pluronic® F-68, 1 L
    Sales unit: each
    EA
  • P1 Primary Cell 384-well Nucleofector™ Kit
    Compare
    P1 Primary Cell 384-well Nucleofector™ Kit
    Catalog #: V5SP-1010
    For high-throughput transfection of primary cells, e.g. human ADSC or MSC, when working with the 384-well HT NucleofectorTM System.
    Sales unit: items
    ST
  • P1 Primary Cell 96-well Nucleofector<sup class=reg>®</sup> Kit
    Compare
    P1 Primary Cell 96-well Nucleofector® Kit
    Catalog #: V4SP-1096

    For medium-throughput transfection of primary cells, e.g. human ADSc or MSC, when working with the 4D-Nucleofector® 96-well Unit.

    Sales unit: kit
    SA
  • Rat Brain Striatum Astrocytes
    Compare
    Rat Brain Striatum Astrocytes
    Catalog #: R-CPAS-522
    Cryopreserved ampule of Rat Brain Striatum Astrocytes containing ≥ 1 million cells
    Sales unit: Ampule
    AMP
1-10 of 1389 results
  • Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell Generation
    Poster on inducible Cas9 T Cells
  • Synthego_Lonza_Protocol_Genome Editing of Resting T cells
    Technical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
  • PBMC Based T Cell Proliferation Assay
    Protocol instructions
  • Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T Cells
    Instructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
  • Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCs
    Protocol for DC and T Cell Assay from Matched PBMCs
  • Case Study – Improving the Expansion of Patients' T Cells
    In this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
  • Synthego-Lonza Genome Editing of Resting T cells
    Case Study on Genome Editing of Resting T cells
  • cGMP Kit T Optimization Protocol - Nucleofector™ 1/2 Device Series
    cGMP Cell Line Nucleofector Kit T
  • CAR-T Cells – Latest Advances and Outstanding Challenges
    Watch Video